Seeking Alpha

ACOR
Acorda Therapeutics, Inc. - NASDAQ

4/16/2014, 7:57 PM ET
Quote & Analysis Breaking News StockTalk
acor chart
Today 5d 1m 3m 1y 5y 10y
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
FOCUS  |  RELATED  |  TRANSCRIPTS  |  OTHER NEWS & PR
PRO Articles
There are 3 articles on this stock available only to PRO subscribers.
Other Articles
ACOR vs. ETF Alternatives
Company Description

Acorda Therapeutics, Inc. is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of multiple sclerosis, spinal cord injury & other disorders of the central nervous system.

Sector: Healthcare
Industry: Biotechnology
Country: United States